Given that blocking OX40/OX40L signaling has previously shown great therapeutic effects in some mouse models of autoimmune diseases, targeting OX40/OX40L is promising as a new therapeutic approach for these diseases. The gene discussed is TNFRSF4; the disease is autoimmune disease.